Header Logo

Michael Gould

Concepts (609)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
104
2025
260
22.790
Why?
Solitary Pulmonary Nodule
32
2024
33
8.120
Why?
Tomography, X-Ray Computed
48
2025
210
7.550
Why?
Early Detection of Cancer
33
2025
513
6.030
Why?
Carcinoma, Non-Small-Cell Lung
24
2022
50
5.670
Why?
Humans
229
2025
17762
4.400
Why?
Practice Guidelines as Topic
23
2024
321
3.320
Why?
Mass Screening
21
2025
677
3.100
Why?
Neoplasm Staging
31
2022
327
3.000
Why?
Positron-Emission Tomography
18
2017
30
2.610
Why?
Lung
11
2023
62
2.440
Why?
Emergency Service, Hospital
10
2020
368
2.410
Why?
Female
109
2025
12740
2.340
Why?
Male
102
2025
10106
2.300
Why?
Multiple Pulmonary Nodules
9
2022
11
2.280
Why?
Evidence-Based Medicine
16
2016
186
2.270
Why?
Aged
70
2025
6150
2.100
Why?
Smoking
12
2022
483
2.090
Why?
Pulmonary Disease, Chronic Obstructive
10
2022
197
2.020
Why?
Retrospective Studies
35
2023
2461
2.020
Why?
Middle Aged
77
2025
7988
2.010
Why?
Anti-Bacterial Agents
8
2020
141
2.000
Why?
Societies, Medical
17
2023
75
1.900
Why?
Breast Neoplasms
5
2023
954
1.840
Why?
Sinusitis
4
2017
14
1.790
Why?
Venous Thromboembolism
10
2020
53
1.780
Why?
Risk Assessment
25
2020
1101
1.770
Why?
Guideline Adherence
11
2017
157
1.760
Why?
United States
45
2024
4003
1.700
Why?
Adenocarcinoma
6
2016
172
1.690
Why?
Pulmonary Medicine
6
2019
19
1.660
Why?
Critical Illness
8
2022
50
1.600
Why?
Diagnostic Imaging
7
2020
45
1.600
Why?
Pulmonary Embolism
11
2020
44
1.560
Why?
Hospitalization
8
2024
808
1.460
Why?
Carcinoma, Squamous Cell
3
2017
55
1.400
Why?
Hospital Mortality
6
2022
145
1.360
Why?
Practice Patterns, Physicians'
8
2017
331
1.360
Why?
Delivery of Health Care, Integrated
7
2020
535
1.340
Why?
Fibrinolytic Agents
8
2017
44
1.310
Why?
Fluorodeoxyglucose F18
9
2016
11
1.290
Why?
Unnecessary Procedures
6
2019
24
1.290
Why?
Venous Thrombosis
7
2017
21
1.250
Why?
Aged, 80 and over
26
2022
1923
1.240
Why?
Patient Selection
8
2024
190
1.190
Why?
Pulmonary Fibrosis
6
2008
9
1.180
Why?
Outcome Assessment (Health Care)
10
2018
228
1.150
Why?
Pandemics
6
2022
287
1.130
Why?
Biomarkers, Tumor
3
2017
143
1.110
Why?
Decision Support Techniques
6
2013
88
1.110
Why?
Adrenal Cortex Hormones
3
2022
68
1.090
Why?
Critical Care
7
2023
71
1.080
Why?
Prognosis
17
2020
609
1.050
Why?
Risk Factors
29
2022
3356
1.010
Why?
Referral and Consultation
2
2022
169
1.000
Why?
Predictive Value of Tests
14
2023
354
0.980
Why?
Coronavirus Infections
3
2020
49
0.980
Why?
Quality Assurance, Health Care
5
2014
169
0.980
Why?
Pneumonia, Viral
3
2020
56
0.980
Why?
Depression
6
2023
505
0.970
Why?
Quality of Life
11
2019
510
0.960
Why?
Interleukin 1 Receptor Antagonist Protein
2
2022
12
0.920
Why?
Tomography, Emission-Computed
6
2003
6
0.880
Why?
Anticoagulants
9
2022
127
0.870
Why?
Lung Diseases
7
2016
42
0.870
Why?
Quality of Health Care
4
2018
326
0.870
Why?
Pneumonia
3
2019
51
0.860
Why?
Veterans
5
2022
143
0.850
Why?
Adult
42
2025
7678
0.850
Why?
Surveys and Questionnaires
17
2024
1321
0.840
Why?
Lymph Nodes
3
2017
17
0.830
Why?
Treatment Outcome
20
2020
1260
0.830
Why?
Heparin
7
2014
9
0.820
Why?
Incidental Findings
5
2022
26
0.810
Why?
Patient Readmission
2
2014
164
0.810
Why?
Sensitivity and Specificity
19
2016
304
0.810
Why?
Radiography, Thoracic
9
2020
19
0.810
Why?
Postoperative Complications
6
2017
102
0.790
Why?
Antibodies, Monoclonal, Humanized
2
2020
24
0.780
Why?
Betacoronavirus
3
2020
35
0.770
Why?
California
16
2025
2326
0.770
Why?
Radiopharmaceuticals
9
2016
12
0.760
Why?
Exercise Therapy
4
2019
71
0.750
Why?
Probability
7
2022
79
0.750
Why?
Community Health Services
1
2022
83
0.740
Why?
Clinical Competence
4
2017
99
0.740
Why?
Prospective Studies
16
2017
1279
0.740
Why?
Catheterization, Central Venous
2
2016
12
0.740
Why?
Anti-Inflammatory Agents
2
2020
25
0.740
Why?
Mediastinal Neoplasms
3
2006
3
0.730
Why?
Medical Overuse
2
2018
13
0.730
Why?
Decision Making
6
2022
183
0.710
Why?
Follow-Up Studies
14
2020
1213
0.710
Why?
Severity of Illness Index
5
2016
455
0.710
Why?
Algorithms
7
2012
239
0.710
Why?
Watchful Waiting
2
2019
18
0.700
Why?
Cytokines
1
2020
30
0.700
Why?
Fibrin Fibrinogen Degradation Products
2
2020
7
0.690
Why?
Intensive Care Units
8
2022
105
0.680
Why?
Thrombolytic Therapy
3
2009
20
0.670
Why?
Heparin, Low-Molecular-Weight
6
2017
10
0.660
Why?
Brain Neoplasms
2
2017
15
0.660
Why?
Time Factors
11
2015
1093
0.650
Why?
Patient Discharge
3
2016
154
0.640
Why?
Lymphatic Metastasis
4
2017
29
0.640
Why?
Bronchoscopy
5
2017
8
0.640
Why?
Hypertension, Pulmonary
3
2009
8
0.620
Why?
Comorbidity
9
2025
597
0.620
Why?
Tissue Plasminogen Activator
4
2016
23
0.610
Why?
Survival Rate
10
2016
260
0.610
Why?
Outcome and Process Assessment (Health Care)
4
2017
102
0.610
Why?
Uterine Cervical Neoplasms
3
2025
125
0.610
Why?
Papillomavirus Infections
3
2025
139
0.600
Why?
Cost-Benefit Analysis
12
2017
250
0.590
Why?
Endosonography
3
2017
9
0.590
Why?
Education, Continuing
1
2017
3
0.590
Why?
Antimicrobial Stewardship
1
2017
7
0.590
Why?
Hemorrhage
9
2020
62
0.590
Why?
Diagnosis, Differential
11
2014
60
0.590
Why?
Mediastinum
1
2017
1
0.580
Why?
Craniocerebral Trauma
1
2017
10
0.580
Why?
Population Surveillance
2
2016
264
0.570
Why?
Health Plan Implementation
1
2017
36
0.560
Why?
Sleep Wake Disorders
3
2016
37
0.560
Why?
Pragmatic Clinical Trials as Topic
4
2022
61
0.560
Why?
Patient Satisfaction
2
2017
212
0.550
Why?
Cohort Studies
13
2025
2586
0.550
Why?
Lung Transplantation
4
2009
7
0.540
Why?
Sepsis
2
2016
70
0.540
Why?
Registries
6
2019
472
0.540
Why?
Catheter-Related Infections
1
2016
3
0.530
Why?
Electronic Health Records
7
2017
697
0.530
Why?
Neuroimaging
1
2016
3
0.520
Why?
Community-Acquired Infections
1
2016
23
0.520
Why?
Logistic Models
9
2017
927
0.510
Why?
Biopsy, Fine-Needle
2
2013
2
0.500
Why?
Magnetic Resonance Imaging
1
2016
106
0.490
Why?
Biomedical Research
4
2020
86
0.480
Why?
Primary Health Care
4
2017
769
0.470
Why?
Health Knowledge, Attitudes, Practice
3
2024
382
0.460
Why?
Cancer Care Facilities
1
2014
4
0.460
Why?
Hospitals, Veterans
4
2014
34
0.460
Why?
Ambulatory Care
1
2015
247
0.430
Why?
Motor Activity
2
2015
212
0.430
Why?
Quality Indicators, Health Care
2
2014
181
0.430
Why?
Health Maintenance Organizations
1
2015
417
0.430
Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
2013
2
0.430
Why?
Thoracic Diseases
1
2012
2
0.420
Why?
Physicians, Primary Care
1
2013
72
0.420
Why?
End Stage Liver Disease
1
2012
9
0.410
Why?
Age Factors
8
2020
918
0.410
Why?
Pattern Recognition, Automated
1
2012
2
0.410
Why?
Drug Costs
2
2014
34
0.410
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2012
7
0.410
Why?
Medical Oncology
2
2023
32
0.410
Why?
Biopsy
4
2016
75
0.400
Why?
Surgical Procedures, Operative
1
2012
16
0.390
Why?
Cause of Death
2
2015
181
0.390
Why?
Delivery of Health Care
6
2022
415
0.390
Why?
Asthma
3
2007
385
0.380
Why?
Withholding Treatment
1
2011
26
0.380
Why?
Acute Disease
5
2017
142
0.380
Why?
Respiration, Artificial
4
2023
37
0.380
Why?
Natural Language Processing
1
2012
58
0.380
Why?
Biopsy, Needle
6
2013
13
0.380
Why?
Randomized Controlled Trials as Topic
10
2022
328
0.380
Why?
Thromboembolism
2
2014
32
0.370
Why?
Health Status
4
2016
298
0.370
Why?
Sex Factors
7
2016
644
0.370
Why?
Multicenter Studies as Topic
2
2022
86
0.360
Why?
Odds Ratio
5
2015
671
0.360
Why?
Multivariate Analysis
6
2017
568
0.360
Why?
Chronic Disease
5
2022
428
0.360
Why?
Antiviral Agents
2
2009
95
0.360
Why?
Attitude to Health
4
2012
164
0.350
Why?
Patient Care Team
3
2016
113
0.350
Why?
Health Priorities
2
2020
26
0.350
Why?
Models, Biological
2
2007
30
0.350
Why?
Anxiety
4
2022
151
0.350
Why?
Research Design
9
2020
376
0.350
Why?
Incidence
6
2015
1266
0.350
Why?
Mediastinoscopy
4
2017
5
0.350
Why?
Medical Audit
2
2016
38
0.350
Why?
National Health Programs
1
2009
9
0.340
Why?
Neuraminidase
1
2009
1
0.330
Why?
Zanamivir
1
2009
1
0.330
Why?
Oseltamivir
1
2009
3
0.330
Why?
Survival Analysis
6
2017
215
0.330
Why?
Disease Outbreaks
1
2009
36
0.330
Why?
Disease Progression
8
2019
264
0.320
Why?
ROC Curve
5
2017
77
0.310
Why?
Mentoring
2
2019
26
0.310
Why?
Radiation Dosage
5
2019
12
0.310
Why?
Quality Improvement
4
2020
194
0.310
Why?
Health Care Costs
2
2009
229
0.310
Why?
Pulmonary Artery
1
2008
3
0.300
Why?
Survivors
2
2022
149
0.300
Why?
Respiration
1
2008
8
0.300
Why?
Respiratory Hypersensitivity
1
2007
1
0.300
Why?
Respiratory Insufficiency
2
2023
17
0.290
Why?
Antibodies, Monoclonal
1
2007
25
0.290
Why?
Continuity of Patient Care
1
2008
105
0.290
Why?
Research
3
2023
65
0.290
Why?
Professional-Patient Relations
2
2017
47
0.280
Why?
Decision Support Systems, Clinical
2
2017
53
0.280
Why?
Anti-Asthmatic Agents
1
2007
85
0.280
Why?
Postoperative Hemorrhage
2
2017
8
0.280
Why?
Walking
3
2019
85
0.280
Why?
Research Report
2
2020
22
0.280
Why?
Qualitative Research
3
2023
256
0.270
Why?
Combined Modality Therapy
3
2013
145
0.270
Why?
Pneumonectomy
2
2016
7
0.270
Why?
Culture
2
2016
25
0.270
Why?
Attitude of Health Personnel
3
2017
213
0.260
Why?
Influenza, Human
1
2009
265
0.260
Why?
Oxyhemoglobins
1
2005
1
0.260
Why?
Pyridones
1
2005
8
0.260
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2008
172
0.250
Why?
Sickness Impact Profile
2
2005
25
0.250
Why?
Cough
2
2015
22
0.250
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2005
65
0.240
Why?
Dalteparin
2
2014
2
0.240
Why?
Preventive Health Services
2
2017
160
0.240
Why?
Epoprostenol
1
2004
1
0.240
Why?
American Cancer Society
1
2024
12
0.240
Why?
Young Adult
6
2020
2461
0.230
Why?
Stroke
3
2016
315
0.230
Why?
Enteral Nutrition
1
2004
6
0.230
Why?
Observational Studies as Topic
2
2022
47
0.230
Why?
Veterans Health
2
2014
21
0.230
Why?
Judgment
1
2024
3
0.230
Why?
Mammography
2
2015
169
0.230
Why?
Adolescent
9
2020
3685
0.220
Why?
Noninvasive Ventilation
1
2023
11
0.210
Why?
Hospital Costs
3
2014
39
0.210
Why?
Antihypertensive Agents
1
2004
161
0.210
Why?
Socioeconomic Factors
3
2016
630
0.210
Why?
Cross Infection
1
2003
27
0.210
Why?
Medical Records
3
2015
100
0.210
Why?
Dexamethasone
1
2022
12
0.210
Why?
Spinal Cord Injuries
1
2002
5
0.200
Why?
Managed Care Programs
2
2015
325
0.200
Why?
Proportional Hazards Models
4
2016
710
0.200
Why?
Policy
1
2022
18
0.200
Why?
Patient Education as Topic
2
2022
212
0.200
Why?
Ventilators, Mechanical
1
2002
1
0.200
Why?
Pneumonia, Bacterial
1
2002
7
0.200
Why?
Radiography
4
2015
39
0.200
Why?
Needs Assessment
1
2002
69
0.200
Why?
Respiratory Function Tests
3
2013
32
0.190
Why?
Immunologic Factors
2
2019
29
0.190
Why?
Urologic Surgical Procedures
3
2017
7
0.190
Why?
Patient Acceptance of Health Care
2
2024
390
0.190
Why?
Health Services Research
3
2022
231
0.190
Why?
Cross-Sectional Studies
5
2016
1330
0.190
Why?
Exercise Test
2
2015
44
0.190
Why?
Inpatients
2
2020
81
0.190
Why?
Smoking Cessation
3
2017
193
0.190
Why?
Women's Health
1
2002
201
0.190
Why?
Glucose-6-Phosphate
1
2001
1
0.190
Why?
Aging
1
2002
162
0.180
Why?
Radiologists
1
2020
4
0.180
Why?
Bacterial Infections
1
2000
9
0.180
Why?
Lymphoproliferative Disorders
1
2000
1
0.180
Why?
Canada
3
2017
66
0.180
Why?
Calcium Channel Blockers
1
2020
14
0.180
Why?
Confidence Intervals
3
2008
237
0.180
Why?
Urinary Tract Infections
1
2000
20
0.180
Why?
Healthcare Disparities
2
2015
203
0.180
Why?
Counseling
1
2022
189
0.180
Why?
Early Medical Intervention
1
2020
10
0.180
Why?
Patient Portals
1
2021
24
0.180
Why?
Government Programs
1
2020
11
0.180
Why?
Neurotoxicity Syndromes
1
2020
3
0.170
Why?
Longitudinal Studies
2
2020
719
0.170
Why?
Research Personnel
1
2020
27
0.170
Why?
Medicare
3
2022
205
0.170
Why?
Cephalosporins
1
2020
8
0.170
Why?
Models, Statistical
2
2020
178
0.170
Why?
Likelihood Functions
2
2012
45
0.170
Why?
Angiotensin Receptor Antagonists
1
2020
53
0.170
Why?
Guidelines as Topic
1
2020
40
0.170
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2020
86
0.170
Why?
Genes, cdc
1
2019
1
0.170
Why?
Income
2
2017
90
0.170
Why?
Mental Disorders
1
2022
280
0.160
Why?
Editorial Policies
1
2019
5
0.160
Why?
Periodicals as Topic
1
2019
14
0.160
Why?
Sex Distribution
3
2015
190
0.160
Why?
Age Distribution
3
2015
246
0.160
Why?
Bronchodilator Agents
2
2015
21
0.160
Why?
Meta-Analysis as Topic
1
1998
32
0.160
Why?
Thrombosis
2
2012
11
0.150
Why?
Patient Transfer
1
2018
23
0.150
Why?
Health Care Surveys
2
2016
230
0.150
Why?
Disease Management
2
2016
135
0.150
Why?
Quality-Adjusted Life Years
4
2014
38
0.150
Why?
Simulation Training
1
2017
4
0.150
Why?
Carcinoma, Bronchogenic
1
1997
1
0.140
Why?
Multilevel Analysis
1
2017
12
0.140
Why?
Fellowships and Scholarships
1
2017
10
0.140
Why?
Cardiopulmonary Resuscitation
1
2017
15
0.140
Why?
Interrupted Time Series Analysis
1
2017
25
0.140
Why?
Efficiency, Organizational
1
2017
32
0.140
Why?
Tobacco Use Disorder
1
2017
49
0.140
Why?
Students, Medical
1
2017
18
0.140
Why?
Urologic Neoplasms
1
2017
7
0.140
Why?
Patient Care
1
2017
35
0.140
Why?
Communication
2
2023
194
0.140
Why?
Urologic Diseases
1
2017
6
0.140
Why?
Arthroplasty, Replacement, Knee
1
2017
17
0.140
Why?
Pulmonologists
1
2017
1
0.140
Why?
Ventilation-Perfusion Ratio
1
1997
1
0.140
Why?
Data Collection
5
2013
256
0.140
Why?
Hypoxia
1
1997
8
0.140
Why?
Respiratory Distress Syndrome, Adult
1
1997
9
0.140
Why?
Oncologists
1
2016
7
0.140
Why?
Sleep Medicine Specialty
1
2016
5
0.140
Why?
Aspirin
1
2017
63
0.140
Why?
Asia
1
2016
15
0.140
Why?
Length of Stay
2
2010
181
0.140
Why?
False Positive Reactions
1
2016
26
0.140
Why?
Learning
1
2016
10
0.140
Why?
Palliative Care
1
2017
61
0.130
Why?
Preoperative Care
1
2016
19
0.130
Why?
Hospitals, Community
1
2016
23
0.130
Why?
Translational Medical Research
1
2016
35
0.130
Why?
Education, Medical, Continuing
1
2016
30
0.130
Why?
Advisory Committees
1
2017
113
0.130
Why?
Program Evaluation
1
2017
223
0.130
Why?
Precision Medicine
1
2016
28
0.130
Why?
Health Resources
1
2016
37
0.130
Why?
Tumor Burden
1
2016
19
0.130
Why?
Hypertension
1
2020
504
0.130
Why?
Bone Neoplasms
1
2015
9
0.130
Why?
Mid-Atlantic Region
1
2015
9
0.130
Why?
Sampling Studies
1
2015
51
0.130
Why?
Northwestern United States
1
2015
53
0.130
Why?
Neoplasm Grading
1
2015
48
0.130
Why?
Pediatrics
1
2017
160
0.130
Why?
Colorectal Neoplasms
2
2021
615
0.130
Why?
Habits
1
2015
7
0.130
Why?
Somatoform Disorders
1
2015
6
0.130
Why?
Tics
1
2015
3
0.130
Why?
Focus Groups
4
2016
147
0.120
Why?
Ethnic Groups
2
2016
485
0.120
Why?
Recurrence
3
2000
188
0.120
Why?
Health Status Indicators
2
2005
64
0.120
Why?
Drug Therapy, Combination
2
2007
114
0.120
Why?
Consensus
3
2020
41
0.120
Why?
Papillomaviridae
2
2025
58
0.120
Why?
Stress, Psychological
1
2016
141
0.120
Why?
Infant
2
2016
1192
0.120
Why?
Clinical Trials as Topic
4
2012
132
0.110
Why?
Health Facilities
1
2014
17
0.110
Why?
Insurance Coverage
2
2016
106
0.110
Why?
Drug Administration Schedule
3
2012
98
0.110
Why?
Health Services Accessibility
2
2014
292
0.110
Why?
Internet
1
2016
231
0.110
Why?
Reproducibility of Results
5
2008
381
0.110
Why?
Health Expenditures
1
2014
75
0.110
Why?
Biomarkers
3
2012
303
0.110
Why?
Exercise
1
2018
492
0.110
Why?
National Academies of Science, Engineering, and Medicine (U.S.) Health and Medicine Division
1
2013
5
0.110
Why?
United States Department of Veterans Affairs
1
2014
128
0.110
Why?
Physical Examination
1
2013
20
0.110
Why?
Review Literature as Topic
1
2013
12
0.110
Why?
Medical History Taking
1
2013
35
0.110
Why?
Patient-Centered Care
1
2015
197
0.110
Why?
Anti-Infective Agents
2
2003
15
0.110
Why?
Diagnostic Tests, Routine
1
2013
20
0.110
Why?
Insurance, Health
2
2014
183
0.110
Why?
Telemedicine
1
2016
186
0.100
Why?
Policy Making
1
2012
15
0.100
Why?
Patient Preference
1
2013
48
0.100
Why?
APACHE
1
2012
11
0.100
Why?
Information Dissemination
1
2012
51
0.100
Why?
Stockings, Compression
1
2012
1
0.100
Why?
Intermittent Pneumatic Compression Devices
1
2012
2
0.100
Why?
Aminoglycosides
2
2003
3
0.100
Why?
Fluoroquinolones
2
2003
7
0.100
Why?
Health Services Misuse
1
2011
14
0.100
Why?
Diagnostic Errors
1
2011
28
0.100
Why?
South Carolina
2
2025
17
0.100
Why?
Censuses
1
2012
31
0.100
Why?
Hispanic Americans
2
2012
404
0.100
Why?
Prevalence
4
2015
886
0.100
Why?
Physician-Patient Relations
1
2013
188
0.090
Why?
Confounding Factors (Epidemiology)
2
2010
86
0.090
Why?
Personality Tests
1
1990
1
0.090
Why?
Clinical Laboratory Information Systems
1
2010
2
0.090
Why?
Cross-Cultural Comparison
1
1990
15
0.090
Why?
Child Behavior Disorders
1
1990
17
0.090
Why?
Risk Adjustment
1
2010
24
0.090
Why?
Tissue Distribution
1
2009
6
0.090
Why?
Catheterization, Swan-Ganz
1
2009
2
0.090
Why?
Risk
3
2012
517
0.080
Why?
Embolization, Therapeutic
1
2009
6
0.080
Why?
International Cooperation
1
2009
17
0.080
Why?
Nausea
1
2009
8
0.080
Why?
Liver Transplantation
1
2009
7
0.080
Why?
Vomiting
1
2009
13
0.080
Why?
Influenza A virus
1
2009
13
0.080
Why?
Liver Diseases
1
2009
23
0.080
Why?
Health Care Rationing
1
2009
12
0.080
Why?
Epidemiologic Methods
1
2009
81
0.080
Why?
Neoplasm Recurrence, Local
1
2011
246
0.080
Why?
Acute Lung Injury
1
2009
3
0.080
Why?
Tuberculosis
1
2009
23
0.080
Why?
Neoplasm Metastasis
3
2017
31
0.080
Why?
Thoracoscopy
1
2008
3
0.080
Why?
Waiting Lists
2
2009
12
0.080
Why?
Tomography, Emission-Computed, Single-Photon
1
2008
1
0.080
Why?
Delphi Technique
1
2008
33
0.080
Why?
Image Interpretation, Computer-Assisted
1
2008
12
0.070
Why?
Reference Standards
2
2006
15
0.070
Why?
Life Expectancy
2
2017
33
0.070
Why?
Forced Expiratory Volume
1
2008
69
0.070
Why?
Antibodies, Anti-Idiotypic
1
2007
2
0.070
Why?
Omalizumab
1
2007
4
0.070
Why?
Paraneoplastic Syndromes
1
2007
2
0.070
Why?
Genetic Counseling
2
1999
26
0.070
Why?
Dose-Response Relationship, Drug
1
2008
129
0.070
Why?
Inflammation
1
2008
63
0.070
Why?
Child
4
2017
2491
0.070
Why?
Positron Emission Tomography Computed Tomography
2
2017
2
0.070
Why?
Carcinoid Tumor
1
1986
1
0.070
Why?
Abdominal Neoplasms
1
1986
2
0.070
Why?
Multiple Sclerosis, Relapsing-Remitting
1
2006
16
0.070
Why?
Immunohistochemistry
1
2006
44
0.070
Why?
Calcaneus
1
2006
5
0.070
Why?
Physicians
2
2016
137
0.070
Why?
Hospitals, University
1
2005
16
0.060
Why?
Body Mass Index
2
2015
964
0.060
Why?
Social Support
2
2019
206
0.060
Why?
Self Report
2
2019
253
0.060
Why?
Osteoporosis
1
2006
75
0.060
Why?
Florida
1
2025
9
0.060
Why?
Polysaccharides
2
2017
3
0.060
Why?
Heart-Lung Transplantation
1
2005
2
0.060
Why?
Terminology as Topic
1
2005
17
0.060
Why?
Data Interpretation, Statistical
2
2020
77
0.060
Why?
Papanicolaou Test
1
2024
37
0.060
Why?
Airway Obstruction
1
2004
4
0.060
Why?
Vaginal Smears
1
2024
48
0.060
Why?
Perception
1
2024
58
0.060
Why?
Exercise Tolerance
1
2004
13
0.060
Why?
Case-Control Studies
2
2018
1120
0.060
Why?
Dyspnea
1
2004
48
0.060
Why?
Occult Blood
2
2021
154
0.050
Why?
Australia
2
2014
22
0.050
Why?
Academic Medical Centers
1
2003
30
0.050
Why?
Kaplan-Meier Estimate
2
2016
129
0.050
Why?
Heart Defects, Congenital
1
2003
37
0.050
Why?
Oxygen
1
2023
16
0.050
Why?
Embolism, Air
1
2003
1
0.050
Why?
Arteries
1
2003
8
0.050
Why?
Penicillanic Acid
1
2003
1
0.050
Why?
Piperacillin
1
2003
1
0.050
Why?
Linear Models
3
2010
231
0.050
Why?
Colonic Neoplasms
1
2004
156
0.050
Why?
Iatrogenic Disease
1
2022
8
0.050
Why?
Chemotherapy, Adjuvant
1
2022
73
0.050
Why?
Ontario
1
2002
16
0.050
Why?
Sexuality
1
2002
11
0.050
Why?
Morbidity
1
2022
59
0.050
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2022
46
0.050
Why?
Stress Disorders, Post-Traumatic
1
2022
58
0.050
Why?
Adaptation, Psychological
1
2002
77
0.050
Why?
Inhalation Exposure
1
2001
5
0.050
Why?
Occupational Diseases
1
2001
41
0.050
Why?
Respiratory Tract Diseases
1
2001
25
0.050
Why?
Occupational Exposure
1
2001
67
0.050
Why?
beta-Lactams
1
2000
1
0.050
Why?
Anti-Infective Agents, Urinary
1
2000
2
0.050
Why?
Drug Resistance, Bacterial
1
2000
15
0.050
Why?
Epstein-Barr Virus Infections
1
2000
4
0.050
Why?
Herpesvirus 4, Human
1
2000
6
0.050
Why?
Patient Participation
1
2022
134
0.040
Why?
Education
1
2020
17
0.040
Why?
Resource Allocation
1
2020
5
0.040
Why?
Pedigree
2
1999
60
0.040
Why?
Health Policy
2
2015
123
0.040
Why?
Antibodies, Viral
1
2000
65
0.040
Why?
Pregnancy
3
2000
1524
0.040
Why?
Organizational Objectives
1
2019
18
0.040
Why?
Clinical Decision-Making
1
2019
34
0.040
Why?
Thoracotomy
1
1999
1
0.040
Why?
Fees and Charges
1
1999
5
0.040
Why?
Double-Blind Method
1
1999
155
0.040
Why?
Analysis of Variance
1
1999
159
0.040
Why?
Family Practice
1
1999
44
0.040
Why?
Obstetrics
1
1999
22
0.040
Why?
Models, Theoretical
1
1999
70
0.040
Why?
Minimally Invasive Surgical Procedures
1
1998
6
0.040
Why?
Coronary Artery Bypass
1
1998
26
0.040
Why?
Mortality
2
2016
118
0.040
Why?
Peptidyl-Dipeptidase A
1
1997
1
0.040
Why?
Receptors, Angiotensin
1
1997
3
0.040
Why?
Psychometrics
2
2005
121
0.040
Why?
Albuminuria
1
1997
38
0.040
Why?
Enoxaparin
1
2017
1
0.040
Why?
Factor Xa Inhibitors
1
2017
10
0.040
Why?
Pulmonary Gas Exchange
1
1997
4
0.030
Why?
Smoking Prevention
1
1997
54
0.030
Why?
Health Promotion
2
2016
281
0.030
Why?
Organizational Policy
1
2016
12
0.030
Why?
Child, Preschool
2
2012
1419
0.030
Why?
Patient Compliance
1
1999
300
0.030
Why?
Pilot Projects
1
2017
218
0.030
Why?
Warfarin
1
2017
74
0.030
Why?
Comprehension
1
2016
17
0.030
Why?
Epidemiologic Studies
1
2016
29
0.030
Why?
Regression Analysis
1
2017
300
0.030
Why?
Diffusion of Innovation
1
2016
42
0.030
Why?
Minority Groups
2
2013
101
0.030
Why?
Heart Rate
1
2016
41
0.030
Why?
Interleukin-2
1
1995
3
0.030
Why?
Immunotherapy
1
1995
6
0.030
Why?
Health Education
1
2016
111
0.030
Why?
Lymphoma, AIDS-Related
1
1995
18
0.030
Why?
Sarcoma, Kaposi
1
1995
12
0.030
Why?
Spirometry
1
2015
65
0.030
Why?
Syndrome
1
2015
28
0.030
Why?
Self Efficacy
1
2015
68
0.030
Why?
Patient Outcome Assessment
1
2015
28
0.030
Why?
Cognitive Dysfunction
1
2016
50
0.030
Why?
Saudi Arabia
1
2014
1
0.030
Why?
Brazil
1
2014
7
0.030
Why?
Models, Economic
1
2014
19
0.030
Why?
Global Health
1
2015
33
0.030
Why?
Cost Savings
1
2014
23
0.030
Why?
North America
1
2014
42
0.030
Why?
Thrombocytopenia
1
2014
15
0.030
Why?
Clinical Protocols
1
2014
43
0.030
Why?
Motivation
1
2015
131
0.030
Why?
Blood Pressure
1
2016
302
0.030
Why?
Health Services
1
2014
112
0.030
Why?
Suicide
1
1994
124
0.030
Why?
Grounded Theory
1
2012
5
0.030
Why?
Uncertainty
1
2012
7
0.030
Why?
Fear
1
2012
14
0.030
Why?
Dementia
1
1994
112
0.030
Why?
Infusions, Intravenous
1
2012
10
0.020
Why?
Long-Term Care
1
2012
22
0.020
Why?
Vitamin K
1
2012
15
0.020
Why?
International Normalized Ratio
1
2012
22
0.020
Why?
Orthopedic Procedures
1
2012
6
0.020
Why?
Administration, Oral
1
2012
85
0.020
Why?
Monte Carlo Method
1
2011
15
0.020
Why?
Markov Chains
1
2011
23
0.020
Why?
Risk Reduction Behavior
1
2012
108
0.020
Why?
Family Characteristics
1
2012
55
0.020
Why?
African Americans
1
1994
472
0.020
Why?
Factor Analysis, Statistical
1
2011
35
0.020
Why?
Educational Status
1
2012
200
0.020
Why?
African Continental Ancestry Group
1
2012
162
0.020
Why?
Personality Disorders
1
1990
2
0.020
Why?
Multi-Institutional Systems
1
2010
2
0.020
Why?
Puerto Rico
1
1990
5
0.020
Why?
Medically Uninsured
1
2010
44
0.020
Why?
Alcoholism
1
1994
348
0.020
Why?
Poverty
1
2012
167
0.020
Why?
Psychiatric Status Rating Scales
1
1990
125
0.020
Why?
Diabetes Mellitus, Type 2
1
1997
755
0.020
Why?
Cost of Illness
1
2010
92
0.020
Why?
Tuberculin Test
1
2009
2
0.020
Why?
Isoniazid
1
2009
3
0.020
Why?
Mycobacterium tuberculosis
1
2009
5
0.020
Why?
Antitubercular Agents
1
2009
9
0.020
Why?
Tissue and Organ Procurement
1
2009
4
0.020
Why?
Cystic Fibrosis
1
2009
8
0.020
Why?
Idiopathic Pulmonary Fibrosis
1
2009
5
0.020
Why?
Residence Characteristics
1
2012
250
0.020
Why?
Medicaid
1
2010
190
0.020
Why?
HIV Infections
1
1995
696
0.020
Why?
Image Enhancement
1
2008
4
0.020
Why?
Diagnostic Techniques, Respiratory System
1
2007
4
0.020
Why?
Sweden
1
2007
19
0.020
Why?
Anal Canal
1
2006
7
0.020
Why?
Disability Evaluation
1
2006
46
0.020
Why?
Age of Onset
1
2006
79
0.020
Why?
Hip
1
2006
9
0.020
Why?
Spine
1
2006
7
0.020
Why?
Absorptiometry, Photon
1
2006
50
0.020
Why?
Ultrasonography
1
2006
35
0.020
Why?
Bias
1
2006
102
0.020
Why?
Bronchiolitis Obliterans
1
2005
2
0.020
Why?
Kidney
1
2005
52
0.010
Why?
Sigmoidoscopy
1
2004
65
0.010
Why?
Direct Service Costs
1
2003
8
0.010
Why?
Drug Compounding
1
2003
4
0.010
Why?
Forecasting
1
2004
75
0.010
Why?
Costs and Cost Analysis
1
2003
80
0.010
Why?
Colonoscopy
1
2004
253
0.010
Why?
London
1
1999
6
0.010
Why?
Pregnancy, High-Risk
1
1999
4
0.010
Why?
Maternal Age
1
1999
77
0.010
Why?
Polymorphism, Genetic
1
1997
62
0.010
Why?
Genotype
1
1997
227
0.010
Why?
Injections, Subcutaneous
1
1995
4
0.010
Why?
Killer Cells, Natural
1
1995
3
0.010
Why?
Recombinant Proteins
1
1995
14
0.010
Why?
Eosinophils
1
1995
9
0.010
Why?
Prenatal Care
1
1996
129
0.010
Why?
Evaluation Studies as Topic
1
1994
33
0.010
Why?
Demography
1
1994
101
0.010
Why?
Adolescent Behavior
1
1994
127
0.010
Why?
European Continental Ancestry Group
1
1994
529
0.010
Why?
Concepts (609)
Explore
_
Co-Authors (43)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_
-->

© 2025 Kaiser Permanente